- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
Chuangyuan Biotechnology has obtained a new national invention patent authorization.
On November 10, 2023, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate issued by the National Intellectual Property Administration for its independently developed and filed "A Preparation Method and Application of Coagulated Weissman Bacterium IOB502 Fermentation Powder" (Patent No. ZL 202311021294.1).
The invention provides a preparation method for coagulated Weissman bacterium IOB502 fermentation powder and its application in the preparation of foods and medicines for preventing and treating gastroesophageal reflux. The coagulated Weissman bacterium IOB502 fermentation powder formulation obtained by this method has good acid resistance, strong bile salt tolerance, and can effectively balance gastric acid secretion, relieve heartburn and acid reflux, and reduce mucosal damage caused by gastroesophageal reflux. The industrialization of this strain provides a certain method and basis for assisting gastroesophageal reflux.

Related News